Polygenic background contributes to GCK-MODY clinical presentation and glycaemic variability
Murray Leech J, Arni AM, Chundru VK, et al.
Diabetologia. Pub. online 18 Mar 2026.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Artificial intelligence in type 1 diabetes management: a scoping review of randomised controlled trials
Wu Y, Pang J, Xu S, et al.
Diabetes Obes Metab. Pub. online 19 Mar 2026.
Leggi
Dementia risk in type 1 and 2 diabetes: a nationwide population‐based comparison
Jun JE, Kim S, Jeong IK, et al.
Diabetes Obes Metab. Pub. online 19 Mar 2026.
Leggi
Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer’s disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials
Cummings JL, Atri A, Sano M, et al.
Lancet. Pub. online 19 Mar 2026.
Leggi
Data-driven phenotypic clusters of gestational diabetes mellitus and associations with risk of perinatal complications and postpartum diabetes
Zhu Y, Ngo AL, Liao LD, et al.
Diabetes Care. Pub. online 17 Mar 2026.
Leggi
Highly uncontrolled cardiovascular risk in emerging adults with paediatric-onset type 1 diabetes-a cross-sectional analysis from the diabetes prospective follow-up registry DPV
Welters A, Reinauer C, Schwab KO, et al.
Diabetes Obes Metab. Pub. online 16 Mar 2026.
Leggi
Shrunken pore syndrome and risk of cardiovascular disease and all-cause mortality in individuals with type 1 diabetes with and without albuminuria
Harjutsalo V, Thorn LM, Sandholm N, Groop PH; FinnDiane Study Group
Diabetes Care. Pub. online 17 Mar 2026.
Leggi
Association between type 2 diabetes and site-specific fracture risk: a systematic review and meta-analysis of cohort studies including over 13 million participants
Naderpour S, Gillies C, O’Riordan P, et al.
Diabet Med. Pub. online 13 Mar 2026.
Leggi
Obesity treatments and weight changes in clinical practice after discontinuation of semaglutide or tirzepatide
Gasoyan H, Schulte R, Boyer CB, et al.
Diabetes Obes Metab. Pub. online 12 Mar 2026.
Leggi
Cardio‐kidney‐metabolic therapy use among adults with type 1 diabetes and chronic kidney disease
Caramori ML, Repetto E, Perkins C, et al.
Diabetes Obes Metab. Pub. online 12 Mar 2026.
Leggi